Otsu, Japan

Masato Matsuda


Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Takatsuki, JP (1980)
  • Otsu, JP (1999)

Company Filing History:


Years Active: 1980-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masato Matsuda: Innovator in Pharmaceutical Chemistry

Introduction

Masato Matsuda is a notable inventor based in Otsu, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds with therapeutic potential. His work has led to the filing of multiple patents, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Masato Matsuda holds 2 patents that reflect his innovative approach to drug development. His latest patents include the Aminostilbazole derivative and medicine, as well as 9H-Pyrido[3,4-b]indole derivatives. These compounds, particularly the 1-Substituted-9H-pyrido[3,4-b]indole derivatives, are designed to act as inhibitors of xanthine-oxidase. A representative embodiment of his work is the 1-formyl-4-hydroxy-9H-pyrido[3,4-b]indole, which can be synthesized through the processing of Picrasma quassioides.

Career Highlights

Masato Matsuda is currently associated with Nippon Shinyaku Company, Ltd., where he continues to push the boundaries of pharmaceutical research. His career is marked by a commitment to developing new therapeutic agents that can address various health challenges.

Collaborations

Throughout his career, Masato has collaborated with esteemed colleagues such as Shingo Matsumura and Hiroshi Enomoto. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Masato Matsuda's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for new medical advancements that can benefit society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…